Discussion paper DP16599 Testing fractional doses of COVID-19 vaccines Witold Więcek Amrita Ahuja Esha Chaudhuri Michael Kremer Alexandre Simoes Gomes Junior Christopher Snyder Alex Tabarrok Brandon Tan 2 Oct 2021 Development Economics Public Economics
Discussion paper DP16324 Could Vaccine Dose Stretching Reduce COVID-19 Deaths? Witold Więcek Amrita Ahuja Michael Kremer Alexandre Simoes Gomes Junior Christopher Snyder Alex Tabarrok Brandon Tan 3 Jul 2021 Development Economics
Discussion paper DP15433 Optimal Subsidies for Prevention of Infectious Disease Michael Kremer Heidi Williams Christopher Snyder Matthew Goodkin-Gold 6 Nov 2020 Development Economics Industrial Organization O31 L11 I18 D42
VoxEU Column Using global demand calibrations to evaluate policy: Case study of HIV pharmaceuticals Fanele Mashwama Christopher Snyder Michael Kremer 10 May 2019 Competition Policy Health Economics
VoxEU Column Worst-case deadweight loss: Theory and disturbing real-world implications Michael Kremer Christopher Snyder Albert Chen 26 Mar 2019 Competition Policy
Discussion paper DP12751 Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals Michael Kremer Christopher Snyder 22 Feb 2018 Development Economics Industrial Organization O31 L65 F23 I14
VoxEU Column What economists study: A guide for the curious Christopher Snyder 12 Aug 2017 Frontiers of economic research
VoxEU Column Vaccines, drugs, and Zipf distributions Michael Kremer Christopher Snyder Natalia Drozdoff 29 Jan 2016 Health Economics
Discussion paper DP10474 Vaccines vs. Preventives Michael Kremer Christopher Snyder 8 Mar 2015 Development Economics Industrial Organization D42 I18 L11 O31